Orange Book product · Generic (ANDA)
ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
At a glance
Oct 26, 1990
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 26, 1990
36 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
Strength
150MG;180MG;30MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 081096
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
- 1990ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATEGeneric (ANDA)
ANDA 081095 · MIKART
- 1990ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATEGeneric (ANDA)
ANDA 081097 · MIKART
- —CODEINE, ASPIRIN, APAP FORMULA NO. 2Generic (ANDA)
ANDA 085640 · SCHERER LABS
- —CODEINE, ASPIRIN, APAP FORMULA NO. 3Generic (ANDA)
ANDA 085639 · SCHERER LABS
- —CODEINE, ASPIRIN, APAP FORMULA NO. 4Generic (ANDA)
ANDA 085638 · SCHERER LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
